Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS        
Revenue, net $ 348,000 $ 352,000 $ 759,000 $ 817,000
Cost of revenue 336,000 330,000 684,000 737,000
Gross profit 12,000 22,000 75,000 80,000
Operating Expenses:        
Research and development 904,000 1,405,000 2,038,000 2,766,000
Sales and marketing 510,000 676,000 1,208,000 1,425,000
General and administrative 607,000 657,000 1,498,000 1,272,000
Total operating expenses 2,021,000 2,738,000 4,744,000 5,463,000
Loss from operations (2,009,000) (2,716,000) (4,669,000) (5,383,000)
Interest expense (1,352,000) 0 (1,389,000) 0
Change in fair value of warrant liability 5,000 64,000 24,000 175,000
Change in fair value of derivative liability 0 0 0 (171,000)
Other expense, net (39,000) (171,000) (41,000) (3,000)
Loss before provision for income taxes (3,395,000) (2,823,000) (6,075,000) (5,382,000)
Provision for income taxes 3,000 1,000 3,000 7,000
Net loss (3,398,000) (2,824,000) (6,078,000) (5,389,000)
Convertible preferred stock dividend (20,000) (16,000) (40,000) (16,000)
Deemed dividend from warrant repricing (134,000) 0 (134,000) 0
Net loss attributable to common stockholders $ (3,552,000) $ (2,840,000) $ (6,252,000) $ (5,405,000)
Net loss per common share - basic and diluted $ (0.90) $ (3.30) $ (2.42) $ (6.62)
Weighted average number of common shares used in computing net loss per common share 3,936,457 861,337 2,583,528 815,859